CytoMed Therapeutics Limited Interest Received Classified As Operating Activities
CytoMed Therapeutics Limited (GDTC) reported Interest Received Classified As Operating Activities of SGD 2.42 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:InterestReceivedClassifiedAsOperatingActivities · last filed 2026-03-31
SGD
| Period end | Interest Received Classified As Operating Activities 12 month | Interest Received Classified As Operating Activities 12 month as first filed |
|---|---|---|
| 2024-12-31 | 2.42K SGD 20-F · filed 2026-03-31 | |
| 2023-12-31 | 623.00 SGD 20-F · filed 2026-03-31 | 98.99K SGD 20-F · filed 2024-04-22 |
| 2022-12-31 | 2.10K SGD 20-F · filed 2025-04-28 | |
| 2021-12-31 | 3.37K SGD 20-F · filed 2024-04-22 |
USD
| Period end | Interest Received Classified As Operating Activities 12 month |
|---|---|
| 2024-12-31 | $1.77K 20-F · filed 2025-04-28 |
| 2023-12-31 | $75.03K 20-F · filed 2024-04-22 |
| 2022-12-31 | $1.56K 20-F · filed 2023-05-01 |